Patients with T2DM Patients with T2DM Patients with T2DM Patients with T2DM Patients without T2DM Patients without T2DM Patients without T2DM
VARIABLE CLUSTER 1 CLUSTER 2 CLUSTER 3 CLUSTER 4 CLUSTER 5 CLUSTER 6 CLUSTER 7 P
N 201 303 140 263 236 316 475
History of hypertension 191 (95%) 288 (95%) 137 (98%) 253 (96%) 201 (85%) 286 (91%) 408 (86%) <0.001
History of smoking 44 (22%) 99 (33%) 86 (61%) 75 (29%) 127 (54%) 71 (22%) 117 (25%) 0.187
History of alcoholism 19 (9.5%) 48 (16%) 35 (25%) 29 (11%) 61 (26%) 37 (12%) 49 (10%) 0.948
CCI 4.17±2.28 3.64±2.45 5.29±2.49 4.06±2.25 2.67±1.87 1.83±1.78 1.65±1.75 <0.001
Barthel index 81.59±24.12 79.59±23.11 84.61±19.39 79.10±22.90 84.51±19.54 81.29±22.75 81.84±22.55 0.113
Pfeiffer index 1.57±2.04 1.69±2.21 1.22±1.54 1.62±1.82 1.50±1.88 1.63±1.99 1.53±1.91 0.914
HR (bpm) 84.97±22.51 85.51±20.76 85.40±19.90 83.88±21.99 88.68±22,19 86.62±22,49 88.93±24.33 0,001
LVEF 60+10 60+11 60+10 60+10 61.1+10.5 61.3+12 63+13 0.22
LVPWT (mm) 11.67±1.94 11.90±2.42 12.04±1.82 11.66±1.82 12.17±3.52 11.81±7.62 11.44±2.41 0.753
PASP (mmHg) 41.62±13.53 47.01±13.50 46.91±15.93 48.09±15.63 46.57±13.68 44.35±13.03 44.83±14.03 0.122
LAD (mm) 42.67±8.24 45.37±9.65 45.97±8.92 45.89±9.99 47.19±10.03 46.55±9.42 45.07±10.06 0.07
Serum sodium (mEq/L) 138.62±4.67 138.86±4.79 137.79±12.44 138.32±5.11 139.33±4.81 138.70±5.00 139.20±4.94 0.025
Serum potassium (mEq/L) 4.46±0.57 4.37±0.64 4.44±0.54 4.36±0.63 4.30±0.59 4.28±0.61 4.27±0.60 <0.001
Etiology of HF
Hypertensive
101 (51%)
196 (65%)
84 (61%)
178 (68%)
145 (62%)
197 (63%)
312 (66%)
0.420
Ischemic
80 (40%)
48 (16%)
40 (29%)
54 (21%)
36 (15%)
67 (21%)
60 (13%)
<0.001
Alcoholic
0
1 (0.33%)
1 (0.73%)
0
4 (1.7%)
0
1 (0.21%)
0.459
Toxic
0
0
1 (0.73%)
0
0
0
2 (0.42%)
1.000
Hypertrophic
3 (1.5%)
11 (3.7%)
2 (1.5%)
2 (0.76%)
4 (1.7%)
7 (2.2%)
18 (3.8%)
0.300
Others
14 (7.1%)
44 (15%)
9 (6.6%)
28 (11%)
45 (19%)
44 (14%)
78 (17%)
<0.001
NT-ProBNP
4328.45± 5623.14 5054.05± 6646.79 4774.06± 4989.90 4703.97± 6593.10 4963.54± 6093.54 5155.51± 5689.35 5729.33± 7147.94
0,135
New York Heart Association Class
I
23 (12%)
12 (4.0%)
9 (6.5%)
12 (4.6%)
16 (6.8%)
37 (12%)
64 (14%)
<0.001
II
118 (59%)
173 (57%)
67 (48%)
158 (61%)
130 (56%)
198 (63%)
277 (59%)
0.353
III
53 (27%)
109 (36%)
56 (40%)
88 (34%)
81 (35%)
72 (23%)
118 (25%)
<0.001
IV
5 (2.5%)
7 (2.3%)
7 (5.0%)
3 (1.1%)
7 (3.0%)
6 (1.9%)
11 (2.3%)
1.000
Medications
ACEi/ARB
148 (74%)
222 (73%)
92 (66%)
186 (71%)
156 (66%)
190 (60%)
324 (68%)
0.004
Beta-blockers
128 (64%)
172 (57%)
71 (51%)
158 (60%)
94 (40%)
179 (57%)
255 (54%)
0.003
Loop diuretics
176 (88%)
281 (93%)
127 (91%)
229 (87%)
210 (89%)
260 (82%)
409 (86%)
0.007
Thiazides
24 (12%)
37 (12%)
16 (11%)
36 (14%)
16 (6.8%)
33 (10%)
41 (8.6%)
0.009
Potassium- sparing diuretics
34 (17%)
76 (25%)
31 (22%)
62 (24%)
55 (23%)
52 (16%)
99 (21%)
0.220